Ohcanbohtosat - Hoyoung Maeng
- Čájehuvvo 1 - 6 / 6
-
1
Strategies for developing and optimizing cancer vaccines Dahkki Hoyoung Maeng, Jay A. Berzofsky
Almmustuhtton 2019Pré-impressão -
2
Cancer vaccines: translation from mice to human clinical trials Dahkki Hoyoung Maeng, Masaki Terabe, Jay A. Berzofsky
Almmustuhtton 2018Revisão -
3
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization Dahkki William Becker, Purevdorj B. Olkhanud, Noriko Seishima, Paloma A Moreno, Katherine C. Goldfarbmuren, Hoyoung Maeng, Jay A. Berzofsky
Almmustuhtton 2024Artigo -
4
-
5
Oxidative status in iron‐deficiency anemia Dahkki Jongha Yoo, Hoyoung Maeng, Young‐Kyu Sun, Young‐Ah Kim, Dong‐Wook Park, Tae Sung Park, Seung‐Tae Lee, J. Y. Choi
Almmustuhtton 2009Artigo -
6
Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex Dahkki Jillian F. Wise, Zuzana Berkova, Rohit Mathur, Haifeng Zhu, Frank Braun, Rong-Hua Tao, Anita L. Sabichi, Xue Ao, Hoyoung Maeng, Felipe Samaniego
Almmustuhtton 2013Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Internal medicine
Medicine
Cancer
Immunotherapy
Biochemistry
Immune system
Immunology
Antigen
Biology
Cancer immunotherapy
Cancer research
Cancer vaccine
Chemistry
Gene
Anemia
Antioxidant
Apoptosis
Atrial fibrillation
Atrioventricular block
CD8
Cardiology
Catalase
Cell biology
Chimeric antigen receptor
Clinical trial
Cytoplasm
Fas ligand
Genetics
Immune checkpoint
In vivo